Sherif Abaza

542 total citations
29 papers, 306 citations indexed

About

Sherif Abaza is a scholar working on Economics and Econometrics, Finance and General Health Professions. According to data from OpenAlex, Sherif Abaza has authored 29 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Economics and Econometrics, 11 papers in Finance and 6 papers in General Health Professions. Recurrent topics in Sherif Abaza's work include Health Systems, Economic Evaluations, Quality of Life (16 papers), Pharmaceutical Economics and Policy (16 papers) and Healthcare Systems and Reforms (11 papers). Sherif Abaza is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (16 papers), Pharmaceutical Economics and Policy (16 papers) and Healthcare Systems and Reforms (11 papers). Sherif Abaza collaborates with scholars based in Hungary, Egypt and United States. Sherif Abaza's co-authors include Zoltán Kaló, Ahmad Nader Fasseeh, Randa Eldessouki, Finn Børlum Kristensen, Rita Karam, Zoltán Vokó, Mohamed Anwar, Nahed Monsef, Eldaw Suliman and Bertalan Németh and has published in prestigious journals such as Frontiers in Pharmacology, BMJ Open and Value in Health.

In The Last Decade

Sherif Abaza

26 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherif Abaza Hungary 8 120 64 53 44 37 29 306
Jens Grueger United States 6 262 2.2× 38 0.6× 54 1.0× 26 0.6× 6 0.2× 16 374
Doris Holmberg‐Marttila Finland 11 43 0.4× 21 0.3× 74 1.4× 49 1.1× 5 0.1× 16 375
Athanasios Chantzaras Greece 8 104 0.9× 19 0.3× 85 1.6× 4 0.1× 18 0.5× 23 257
Mirta Millares United States 7 142 1.2× 46 0.7× 31 0.6× 28 0.6× 2 0.1× 10 317
Carles Blanch Spain 9 54 0.5× 64 1.0× 41 0.8× 7 0.2× 3 0.1× 28 294
Sudip Shrestha Nepal 10 51 0.4× 27 0.4× 32 0.6× 9 0.2× 2 0.1× 33 353
Adrian Rabe United Kingdom 11 31 0.3× 5 0.1× 32 0.6× 14 0.3× 4 0.1× 16 313
Ken Wei Tan Singapore 10 19 0.2× 19 0.3× 16 0.3× 10 0.2× 3 0.1× 18 349
Aureliano Paolo Finch Netherlands 12 250 2.1× 10 0.2× 109 2.1× 2 0.0× 26 0.7× 26 421
Rachael Thorneloe United Kingdom 9 45 0.4× 96 1.5× 56 1.1× 7 0.2× 13 310

Countries citing papers authored by Sherif Abaza

Since Specialization
Citations

This map shows the geographic impact of Sherif Abaza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherif Abaza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherif Abaza more than expected).

Fields of papers citing papers by Sherif Abaza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherif Abaza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherif Abaza. The network helps show where Sherif Abaza may publish in the future.

Co-authorship network of co-authors of Sherif Abaza

This figure shows the co-authorship network connecting the top 25 collaborators of Sherif Abaza. A scholar is included among the top collaborators of Sherif Abaza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherif Abaza. Sherif Abaza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fasseeh, Ahmad Nader, et al.. (2025). Rare disease challenges and potential actions in the Middle East. International Journal for Equity in Health. 24(1). 56–56. 1 indexed citations
2.
Moukarzel, M, et al.. (2024). Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions. BMJ Open. 14(11). e090344–e090344. 1 indexed citations
3.
Fasseeh, Ahmad Nader, et al.. (2024). Designing a Roadmap for Health Technology Assessment Implementation in Algeria. Cureus. 16(7). e65558–e65558.
4.
Al‐Sabti, Hilal, et al.. (2024). A roadmap towards implementing health technology assessment in Oman. Journal of Health Organization and Management. 38(9). 241–257.
5.
Fasseeh, Ahmad Nader, et al.. (2024). Framework for developing cost-effectiveness analysis threshold: the case of Egypt. Journal of the Egyptian Public Health Association. 99(1). 12–12. 3 indexed citations
6.
Fasseeh, Ahmad Nader, et al.. (2024). Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs. Cureus. 16(2). e55215–e55215. 3 indexed citations
7.
Fasseeh, Ahmad Nader, et al.. (2022). A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt. BMC Medical Informatics and Decision Making. 22(1). 289–289. 3 indexed citations
8.
Fasseeh, Ahmad Nader, et al.. (2022). A roadmap toward implementing health technology assessment in Egypt. Frontiers in Public Health. 10. 896175–896175. 9 indexed citations
9.
Eldessouki, Randa, et al.. (2022). POSB253 Development of a Multi Criteria Decision Analysis (MCDA) Tool for Medical Devices National Procurement in Egypt. Value in Health. 25(1). S176–S176. 1 indexed citations
10.
Fasseeh, Ahmad Nader, et al.. (2022). Healthcare financing in Egypt: a systematic literature review.. Journal of the Egyptian Public Health Association. 97(1). 1–1. 35 indexed citations
11.
Fasseeh, Ahmad Nader, et al.. (2020). Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status. Frontiers in Pharmacology. 11. 15–15. 46 indexed citations
12.
Fasseeh, Ahmad Nader, et al.. (2019). PNS121 PRIVATE HEALTH INSURANCE COLLABORATION WITH PHARMACEUTICAL COMPANIES IN EGYPT. Value in Health. 22. S782–S782. 1 indexed citations
13.
Fasseeh, Ahmad Nader, et al.. (2019). PNS179 HTA IMPLEMENTATION IN MIDDLE EAST AND NORTH AFRICA: COMPARISON OF CURRENT AND PREFERRED STATUS. Value in Health. 22. S315–S316. 2 indexed citations
14.
Fasseeh, Ahmad Nader, et al.. (2019). PNS178 PRIVATE HEALTH INSURANCE PERCEPTION OF THEIR ROLE AFTERWARD UNIVERSAL HEALTH INSURANCE IN EGYPT. Value in Health. 22. S791–S791. 1 indexed citations
15.
Fasseeh, Ahmad Nader, et al.. (2018). PHP178 - ROLE OF SUPPLEMENTARY AND COMPLEMENTARY PRIVATE HEALTH INSURANCE IN SELECTED COUNTRIES. Value in Health. 21. S180–S180. 1 indexed citations
16.
Abaza, Sherif, et al.. (2016). THE EVOLUTION OF PRIVATE HEALTH INSURANCE IN EGYPT WITHIN THE IMPLEMENTATION OF UNIVERSAL HEALTH COVERAGE. Value in Health. 19(3). A291–A291. 1 indexed citations
17.
Hassan, R., et al.. (2015). Pricing Policy for Pharmaceuticals in Egypt: Challenges and Opportunities. Value in Health. 18(7). A523–A523. 1 indexed citations
18.
Abaza, Sherif, et al.. (2013). Cost-Effectiveness of Sapropterin Versus Phenylalanine Free Diet in Patients with Phenylketonuria in Egypt. Value in Health. 16(7). A385–A385. 1 indexed citations
19.
Kaló, Zoltán, et al.. (2013). Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt. Value in Health Regional Issues. 2(2). 319–327. 54 indexed citations
20.
Abaza, Sherif, et al.. (2012). PCV106 Affordability of Anti-Hypertensive Medication in Egypt Under Current Reimbursement Systems. Value in Health. 15(7). A381–A381. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Grueger Breakdown of academic impact, for papers by Doris Holmberg‐Marttila Breakdown of academic impact, for papers by Athanasios Chantzaras Breakdown of academic impact, for papers by Mirta Millares Breakdown of academic impact, for papers by Carles Blanch Breakdown of academic impact, for papers by Sudip Shrestha Breakdown of academic impact, for papers by Adrian Rabe Breakdown of academic impact, for papers by Ken Wei Tan Breakdown of academic impact, for papers by Aureliano Paolo Finch Breakdown of academic impact, for papers by Rachael Thorneloe
Rankless by CCL
2026